Literature DB >> 19273242

The immune control of HTLV-1 infection: selection forces and dynamics.

Charles R M Bangham1, Kiran Meekings, Frederic Toulza, Mohamed Nejmeddine, Endre Majorovits, Becca Asquith, Graham P Taylor.   

Abstract

Cytotoxic T lymphocytes (CTLs) play a central role in the protective immune response to human T-lymphotropic virus 1 (HTLV-1). Here we consider two questions. First, what determines the strength of an individual's HTLV-1-specific CTL response? Second, what controls the rate of expression of HTLV-1 in vivo, which is greater in patients with HAM/TSP than in asymptomatic carriers with the same proviral load? Recent evidence shows that FoxP3+CD4+ T cells are abnormally frequent in HTLV-1 infection, and the frequency of these cells is inversely correlated with the rate of CTL lysis of HTLV-1-infected cells, suggesting that FoxP3+CD4+ cell frequency is an important determinant of the outcome of HTLV-1 infection. There is also new evidence that the rate of expression of HTLV-1 in vivo is associated with the transcriptional activity of the flanking host genome. We suggest that the frequencies of HTLV-1-infected T cell clones in vivo are determined by a dynamic balance between positive and negative selection forces that differ among the clones.

Entities:  

Mesh:

Year:  2009        PMID: 19273242     DOI: 10.2741/3420

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  19 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

2.  miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

3.  Early spatial and temporal events of human T-lymphotropic virus type 1 spread following blood-borne transmission in a rabbit model of infection.

Authors:  Rashade A H Haynes; Bevin Zimmerman; Laurie Millward; Evan Ware; Christopher Premanandan; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

4.  Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.

Authors:  Iris Castro; Teresa M Giret; Diogo M Magnani; Helen S Maxwell; Oliver Umland; Jessica K Perry; Jerilyn K Pecotte; Kathleen M Brasky; Glen N Barber; Ronald C Desrosiers; David I Watkins
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

5.  HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.

Authors:  Rashida Ginwala; Breanna Caruso; Zafar K Khan; Ajinkya Pattekar; Glen M Chew; Michael J Corley; Ronak Loonawat; Steven Jacobson; Sreesha Sreedhar; Lishomwa C Ndhlovu; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-04       Impact factor: 4.147

6.  Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.

Authors:  Rashade A H Haynes; Evan Ware; Christopher Premanandan; Bevin Zimmerman; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

7.  Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo.

Authors:  Linda Zane; David Sibon; Lionel Jeannin; Marc Zandecki; Marie-Hélène Delfau-Larue; Antoine Gessain; Olivier Gout; Christiane Pinatel; Agnès Lançon; Franck Mortreux; Eric Wattel
Journal:  Retrovirology       Date:  2010-03-11       Impact factor: 4.602

8.  Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.

Authors:  Horacio Gómez-Acevedo; Michael Y Li; Steven Jacobson
Journal:  Bull Math Biol       Date:  2009-12-30       Impact factor: 1.758

9.  The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome.

Authors:  Yorifumi Satou; Paola Miyazato; Ko Ishihara; Hiroko Yaguchi; Anat Melamed; Michi Miura; Asami Fukuda; Kisato Nosaka; Takehisa Watanabe; Aileen G Rowan; Mitsuyoshi Nakao; Charles R M Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

10.  Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  Front Microbiol       Date:  2012-12-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.